Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.

<h4>Background</h4> <p>In 2012, the World Health Organization recommended blocking the transmission of Plasmodium falciparum with single low-dose primaquine (SLDPQ, target dose 0.25 mg base/kg body weight), without testing for glucose-6-phosphate dehydrogenase deficiency (G6PDd),...

Full description

Bibliographic Details
Main Authors:	Taylor, W, Naw, H, Maitland, K, Williams, T, Kapulu, M, D'Alessandro, U, Berkley, J, Bejon, P, Okebe, J, Achan, J, Amambua, A, Affara, M, Nwakanma, D, van Geertruyden, J, Mavoko, M, Lutumba, P, Matangila, J, Brasseur, P, Piola, P, Randremanana, R, Lasry, E, Fanello, C, Onyamboko, M, Schramm, B, Yah, Z, Jones, J, Fairhurst, R, Diakite, M, Malenga, G, Molyneux, M, Rwagacondo, C, Obonyo, C, Gadisa, E, Aseffa, A, Loolpapit, M, Henry, M, Dorsey, G, John, C, Sirima, S, Barnes, K, Kremsner, P, Day, N, White, N, Mukaka, M
Format:	Journal article
Language:	English
Published:	BioMed Central 2018

Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.

Similar Items